表紙
市場調查報告書

腦膜炎疫苗的全球市場

Global Market Study on Meningococcal Vaccines: Awareness and Accessibility Instrumenting Inroads into Untapped Markets

出版商 Persistence Market Research 商品編碼 905983
出版日期 內容資訊 英文 249 Pages
商品交期: 2-3個工作天內
價格
Back to Top
腦膜炎疫苗的全球市場 Global Market Study on Meningococcal Vaccines: Awareness and Accessibility Instrumenting Inroads into Untapped Markets
出版日期: 2019年07月18日內容資訊: 英文 249 Pages
簡介

本報告提供全球腦膜炎疫苗市場的相關調查,提供市場機會,需求,成長及阻礙因素,產品類型·年齡層·流通管道·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 摘要整理

第2章 市場概要

  • 市場覆蓋率/分類
  • 市場定義/範圍/限制

第3章 主要市場趨勢

  • 影響市場的主要趨勢
  • 產品革新

第4章 主要成功因素

  • 開發平台分析
  • 最近的產品銷售
  • 推銷策略:各製造廠商
  • 法規方案

第5章 全球腦膜炎疫苗市場需求(銷售額或規模:100萬美元)分析及預測

  • 過去的市場分析
  • 現在及未來市場預測
    • 與前一年同期比較成長趨勢分析

第6章 市場背景

  • 宏觀經濟要素
    • 全球醫療保健支出預測
    • 全球醫藥品的展望
    • 地區醫療市場預測
  • 預測要素-相關性及影響
  • 價值鏈
  • 開發平台分析
  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會分析

第7章 全球腦膜炎疫苗市場分析及預測:各產品類型

  • 簡介/主要調查結果
  • 過去的市場分析
  • 現在/未來市場分析及預測
    • 腦膜炎多糖疫苗(MPSV4)
    • 腦膜炎複合疫苗(MCV4)
    • 血清型B腦膜炎疫苗(MenB-FHpb / MenB-4C)
  • 市場魅力分析

第8章 全球腦膜炎疫苗市場分析及預測:各年齡層

  • 簡介/主要調查結果
  • 過去的市場分析
  • 現在/未來市場分析及預測
    • 幼兒(0-24個月)
    • 兒童
    • 青年及青年成人
    • 大人
  • 市場魅力分析

第9章 全球腦膜炎疫苗市場分析及預測:各流通管道

  • 簡介/主要調查結果
  • 過去的市場分析
  • 現在/未來市場分析及預測
    • 機關
    • 零售
  • 市場魅力分析

第10章 全球腦膜炎疫苗市場分析及預測:各地區

  • 簡介
  • 過去的市場及交易數量分析:各地區
  • 目前市場,交易數量分析及預測:各地區
    • 北美
    • 南美
    • 歐洲
    • 東亞
    • 南亞
    • 大洋洲
    • 中東及非洲地區(MEA)
  • 市場魅力分析

第11章 北美的腦膜炎疫苗市場分析及預測

  • 簡介
  • 過去的市場,及交易數量趨勢分析:市場分類法
  • 市場及交易數量的預測:市場分類法
    • 各國
    • 各產品類型
    • 各年齡
    • 各流通管道
  • 市場魅力分析
  • 市場趨勢
  • 主要市場參與企業:強度製圖
  • 成長要素及規定:影響分析

第12章 南美的腦膜炎疫苗的市場分析及預測

章13章 歐洲的腦膜炎疫苗的市場分析及預測

第14章 南亞的腦膜炎疫苗市場分析及預測

第15章 東亞的腦膜炎疫苗市場分析及預測

第16章 大洋洲的腦膜炎疫苗市場分析及預測

第17章 中東及非洲的腦膜炎疫苗市場分析及預測

第18章 新興國家的腦膜炎疫苗市場分析及預測

  • 簡介
    • 市場銷售額的比例分析:各主要國家
    • 世界VS國的成長比較
  • 中國
    • 簡介
    • PEST分析
    • 市場銷售額的比例分析:市場分類法
    • 市場及分析及預測:市場分類法
  • 印度
  • 巴西

第19章 市場結構分析

  • 市場分析:公司層面(腦膜炎疫苗)
  • 主要企業的市場佔有率分析
  • 品牌佔有率分析
  • 市場影響分析
    • 各地區:企業的足跡
    • 各企業:產品足跡
    • 各企業:流通管道的足跡

第20章 競爭情形

  • 競爭儀表板
  • 競爭:價格分析
  • 競爭的基準
  • 企業簡介
    • Sanofi Pasteur Inc.
    • GlaxoSmithKline
    • Wyeth Pharmaceuticals

第21章 假設及簡稱的使用

第22章 調查方法

目錄

A recent research study published by Persistence Market Research (PMR) evaluates the historical and current scenario of 'Global Meningococcal Vaccine Market' to accurately evaluate its futuristic development. It includes comprehensive information about the key dynamics influencing the market growth, including drivers, restraints, vital trends, and opportunities that are shaping the growth prospects of the meningococcal vaccine market to highlight the opportunistic business potential for market participants. The report also gives comprehensive information about how the meningococcal vaccine market will proceed during the study period, 2019-2029.

The report offers actionable insights about the key aspects and nuances of the meningococcal vaccine market to aid the market enthusiasts take winning decisions. PMR's report also sheds light on the vital trends that are anticipated to impact the growth of the meningococcal vaccine market during the study period. The report covers a key indicator assessment to highlight the various growth prospects of the meningococcal vaccine market and forecast statistics pertaining to the growth of the market in the terms of value (US$ Mn).

The report presents a clear segmentation of the meningococcal vaccine market along with actionable insights on competitive landscape. The report covers the company profiles of the players that are operating in the meningococcal vaccine market, wherein, various development and growth strategies formulated and employed by the market goliaths have been provides in a comprehensive way.

Segmentation:

PMR's study examines the meningococcal vaccine market on the basis of product, age group, distribution channel, and region. The report presents the market dynamics and rapidly changing trends related to the various market segments and how they are impacting the growth of the meningococcal vaccine market.

What are the Key Questions Answered in PMR's Report on Meningococcal Vaccine Market?

The report offers unique information about the meningococcal vaccine market on the basis of detailed research related to the macro and microeconomic factors that are instrumental in shaping the progress of the meningococcal vaccine market. The information mentioned in the report answers to the salient queries for the operating market players and the companies that are eying entry in the meningococcal vaccine market, to assist them formulate winning strategies and make business-driving moves.

  • What are the key development strategies of goliaths in the meningococcal vaccine market?
  • Which meningococcal vaccines product will record highest market revenues in 2022?
  • How market big shots are turning the tables in terms of changing trends to unlock higher sales of meningococcal vaccines?
  • What will be the Y-o-Y growth of meningococcal vaccine market between 2019 and 2022?
  • Which age group created highest traction for meningococcal vaccines in 2018?
  • What ROI can meningococcal vaccine market expect through institutional sales in the next couple of years?

Research Methodology:

The research methodology employed by the PMR analysts for making meningococcal vaccine market report includes detailed research on the basis of primary and secondary resources. By delving in the market-validated information compiled and verified by relevant resources, analysts have provided riveting insights and authentic projection of the meningococcal vaccine market.

During the primary research phase, analysts interviewed C-level executives, raw material suppliers, brand manager, vice presidents, sales and marketing managers, regional managers, and industry players and investors. Based on the information compiled through the interviews of relevant resources, analysts have underlined the development outlook of meningococcal vaccine market.

For secondary research, PMR performed inclusive study of multiple annual report publications, industry association publications, case studies, white papers, research publications, and company website to acquire necessary understanding of the meningococcal vaccine market.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation

4. Key Success Factors

  • 4.1. Pipeline Analysis
  • 4.2. Recent Product Launches
  • 4.3. Promotional Strategies, by Manufacturers
  • 4.4. Regulatory Scenario

5. Global Meningococcal Vaccine Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029

  • 5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
  • 5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029
    • 5.2.1. Y-o-Y Growth Trend Analysis
    • 5.2.2. Absolute $ Opportunity Analysis

6. Market Background

  • 6.1. Macro-Economic Factors
    • 6.1.1. Global Healthcare Spending Outlook
    • 6.1.2. Global Pharmaceutical Outlook
    • 6.1.3. Regional Healthcare Market Outlook
  • 6.2. Forecast Factors - Relevance & Impact
  • 6.3. Value Chain
  • 6.4. Pipeline Analysis
  • 6.5. Market Dynamics
    • 6.5.1. Drivers
    • 6.5.2. Restraints
    • 6.5.3. Opportunity Analysis

7. Global Meningococcal Vaccine Market Analysis 2014-2018 and Forecast 2019-2029, by Product Type

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2014 - 2018
  • 7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2019 - 2029
    • 7.3.1. Meningococcal Polysaccharide Vaccine (MPSV4)
    • 7.3.2. Meningococcal Conjugate Vaccine (MCV4)
    • 7.3.3. Serogroup B Meningococcal Vaccine (MenB-FHpb/MenB-4C)
  • 7.4. Market Attractiveness Analysis By Product Type

8. Global Meningococcal Vaccine Market Analysis 2014-2018 and Forecast 2019-2029, by Age Group

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Age Group, 2014 - 2018
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Age Group, 2019 - 2029
    • 8.3.1. Infants (0-24 months)
    • 8.3.2. Children
    • 8.3.3. Adolescents and Young Adults
    • 8.3.4. Adults
  • 8.4. Market Attractiveness Analysis By Age Group

9. Global Meningococcal Vaccine Market Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014 - 2018
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2019 - 2029
    • 9.3.1. Institutional Sales
      • 9.3.1.1. Hospitals
      • 9.3.1.2. Community Clinics
      • 9.3.1.3. Public Health Agencies
    • 9.3.2. Retail Sales
      • 9.3.2.1. Retail Pharmacy
      • 9.3.2.2. Mail Order Pharmacy
  • 9.4. Market Attractiveness Analysis By Distribution Channel

10. Global Meningococcal Vaccine Market Analysis 2014-2018 and Forecast 2019-2029, by Region

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2014 - 2018
  • 10.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2019 - 2029
    • 10.3.1. North America
    • 10.3.2. Latin America
    • 10.3.3. Europe
    • 10.3.4. East Asia
    • 10.3.5. South Asia
    • 10.3.6. Oceania
    • 10.3.7. Middle East and Africa (MEA)
  • 10.4. Market Attractiveness Analysis By Region

11. North America Meningococcal Vaccine Market Analysis 2014-2018 and Forecast 2019-2029

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2014 - 2018
  • 11.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2019 - 2029
    • 11.3.1. By Country
      • 11.3.1.1. U.S.
      • 11.3.1.2. Canada
    • 11.3.2. By Product Type
    • 11.3.3. By Age Group
    • 11.3.4. By Distribution Channel
  • 11.4. Market Attractiveness Analysis
  • 11.5. Market Trends
  • 11.6. Key Market Participants - Intensity Mapping
  • 11.7. Drivers and Restraints - Impact Analysis

12. Latin America Meningococcal Vaccine Market Analysis 2014-2018 and Forecast 2019-2029

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2014 - 2018
  • 12.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2019 - 2029
    • 12.3.1. By Country
      • 12.3.1.1. Brazil
      • 12.3.1.2. Mexico
      • 12.3.1.3. Rest of Latin America
    • 12.3.2. By Product Type
    • 12.3.3. By Age Group
    • 12.3.4. By Distribution Channel
  • 12.4. Market Attractiveness Analysis
  • 12.5. Market Trends
  • 12.6. Key Market Participants - Intensity Mapping
  • 12.7. Drivers and Restraints - Impact Analysis

13. Europe Meningococcal Vaccine Market Analysis 2014-2018 and Forecast 2019-2029

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2014 - 2018
  • 13.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2019 - 2029
    • 13.3.1. By Country
      • 13.3.1.1. Germany
      • 13.3.1.2. Italy
      • 13.3.1.3. France
      • 13.3.1.4. U.K.
      • 13.3.1.5. Spain
      • 13.3.1.6. BENELUX
      • 13.3.1.7. Russia
      • 13.3.1.8. Rest of Europe
    • 13.3.2. By Product Type
    • 13.3.3. By Age Group
    • 13.3.4. By Distribution Channel
  • 13.4. Market Attractiveness Analysis
  • 13.5. Market Trends
  • 13.6. Key Market Participants - Intensity Mapping
  • 13.7. Drivers and Restraints - Impact Analysis

14. South Asia Meningococcal Vaccine Market Analysis 2014-2018 and Forecast 2019-2029

  • 14.1. Introduction
  • 14.2. Pricing Analysis
  • 14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2014 - 2018
  • 14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2019 - 2029
    • 14.4.1. By Country
      • 14.4.1.1. India
      • 14.4.1.2. Thailand
      • 14.4.1.3. Indonesia
      • 14.4.1.4. Malaysia
      • 14.4.1.5. Rest of South Asia
    • 14.4.2. By Product Type
    • 14.4.3. By Age Group
    • 14.4.4. By Distribution Channel
  • 14.5. Market Attractiveness Analysis
  • 14.6. Market Trends
  • 14.7. Key Market Participants - Intensity Mapping
  • 14.8. Drivers and Restraints - Impact Analysis

15. East Asia Meningococcal Vaccine Market Analysis 2014-2018 and Forecast 2019-2029

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2014 - 2018
  • 15.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2019 - 2029
    • 15.3.1. By Country
      • 15.3.1.1. China
      • 15.3.1.2. Japan
      • 15.3.1.3. South Korea
    • 15.3.2. By Product Type
    • 15.3.3. By Age Group
    • 15.3.4. By Distribution Channel
  • 15.4. Market Attractiveness Analysis
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis

16. Oceania Meningococcal Vaccine Market Analysis 2014-2018 and Forecast 2019-2029

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2014 - 2018
  • 16.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2019 - 2029
    • 16.3.1. By Country
      • 16.3.1.1. Australia
      • 16.3.1.2. New Zealand
    • 16.3.2. By Product Type
    • 16.3.3. By Age Group
    • 16.3.4. By Distribution Channel
  • 16.4. Market Attractiveness Analysis
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis

17. Middle East and Africa Meningococcal Vaccine Market Analysis 2014-2018 and Forecast 2019-2029

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2014 - 2018
  • 17.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2019 - 2029
    • 17.3.1. By Country
      • 17.3.1.1. GCC Countries
      • 17.3.1.2. Turkey
      • 17.3.1.3. Northern Africa
      • 17.3.1.4. South Africa
      • 17.3.1.5. Rest of Middle East and Africa
    • 17.3.2. By Product Type
    • 17.3.3. By Age Group
    • 17.3.4. By Distribution Channel
  • 17.4. Market Attractiveness Analysis
  • 17.5. Market Trends
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis

18. Emerging Countries Meningococcal Vaccine Market Analysis 2014-2018 and Forecast 2019-2029

  • 18.1. Introduction
    • 18.1.1. Market Value Proportion Analysis, By Key Countries
    • 18.1.2. Global Vs. Country Growth Comparison
  • 18.2. China Meningococcal Vaccine Market Analysis
    • 18.2.1. Introduction
    • 18.2.2. PEST Analysis
    • 18.2.3. Market Value Proportion Analysis by Market Taxonomy
    • 18.2.4. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy
      • 18.2.4.1. By Product Type
      • 18.2.4.2. By Age Group
      • 18.2.4.3. By Distribution Channel
  • 18.3. India Meningococcal Vaccine Market Analysis
    • 18.3.1. Introduction
    • 18.3.2. PEST Analysis
    • 18.3.3. Market Value Proportion Analysis by Market Taxonomy
    • 18.3.4. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy
      • 18.3.4.1. By Product Type
      • 18.3.4.2. By Age Group
      • 18.3.4.3. By Distribution Channel
  • 18.4. Brazil Meningococcal Vaccine Market Analysis
    • 18.4.1. Introduction
    • 18.4.2. PEST Analysis
    • 18.4.3. Market Value Proportion Analysis by Market Taxonomy
    • 18.4.4. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy
      • 18.4.4.1. By Product Type
      • 18.4.4.2. By Age Group
      • 18.4.4.3. By Distribution Channel

19. Market Structure Analysis

  • 19.1. Market Analysis by Tier of Companies (Meningococcal Vaccine)
  • 19.2. Market Share Analysis of Top Players
  • 19.3. Brand Share Analysis
  • 19.4. Market Presence Analysis
    • 19.4.1. By Regional footprint of Players
    • 19.4.2. Product foot print by Players
    • 19.4.3. Channel Foot Print by Players

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Pricing Analysis by Competition
  • 20.3. Competition Benchmarking
  • 20.4. Competition Deep Dive
    • 20.4.1. Sanofi Pasteur Inc.
      • 20.4.1.1. Overview
      • 20.4.1.2. Product Portfolio
      • 20.4.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 20.4.1.4. Sales Footprint
      • 20.4.1.5. Strategy Overview
        • 20.4.1.5.1. Marketing Strategy
        • 20.4.1.5.2. Product Strategy
        • 20.4.1.5.3. Channel Strategy
    • 20.4.2. GlaxoSmithKline
      • 20.4.2.1. Overview
      • 20.4.2.2. Product Portfolio
      • 20.4.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 20.4.2.4. Sales Footprint
      • 20.4.2.5. Strategy Overview
        • 20.4.2.5.1. Marketing Strategy
        • 20.4.2.5.2. Product Strategy
        • 20.4.2.5.3. Channel Strategy
    • 20.4.3. Wyeth Pharmaceuticals
      • 20.4.3.1. Overview
      • 20.4.3.2. Product Portfolio
      • 20.4.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 20.4.3.4. Sales Footprint
      • 20.4.3.5. Strategy Overview
        • 20.4.3.5.1. Marketing Strategy
        • 20.4.3.5.2. Product Strategy
        • 20.4.3.5.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology

List of Tables

  • Table 01: Meningococcal Vaccines Market Pipeline Analysis (2018)
  • Table 02: Meningococcal Vaccines Market Pipeline Analysis (2018)
  • Table 03: Meningococcal Vaccines Market Pipeline Analysis (2018)
  • Table 04: Meningococcal Vaccines Market Pipeline Analysis (2018)
  • Table 05: Meningococcal Vaccines Market Pipeline Analysis (2018)
  • Table 06: Factors Considered While Setting Vaccine Prices, By Company
  • Table 07: Factors Considered While Setting Vaccine Prices, By Company
  • Table 08: Global Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
  • Table 09: Global Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Age Group
  • Table 10: Global Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
  • Table 11: Global Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Region
  • Table 12: North America Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Table 13: North America Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
  • Table 14: North America Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Age Group
  • Table 15: North America Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
  • Table 16: Latin America Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Table 17: Latin America Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
  • Table 18: Latin America Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Age Group
  • Table 19: Latin America Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
  • Table 20: Europe Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Table 21: Europe Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
  • Table 22: Europe Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Age Group
  • Table 23: Europe Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
  • Table 24: East Asia Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Table 25: East Asia Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
  • Table 26: East Asia Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Age Group
  • Table 27: East Asia Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
  • Table 28: South Asia Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Table 29: South Asia Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
  • Table 30: South Asia Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Age Group
  • Table 31: South Asia Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
  • Table 32: Oceania Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Table 33: Oceania Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
  • Table 34: Oceania Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Age Group
  • Table 35: Oceania Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
  • Table 36: MEA Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Table 37: MEA Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
  • Table 38: MEA Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Age Group
  • Table 39: MEA Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
  • Table 40: China Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
  • Table 41: China Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Age Group
  • Table 42: China Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
  • Table 43: India Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
  • Table 44: India Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Age Group
  • Table 45: India Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
  • Table 46: Brazil Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
  • Table 47: Brazil Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Age Group
  • Table 48: Brazil Meningococcal Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel

List of Figures

  • Figure 01: Meningococcal Vaccine Market Value ($ Mn), By Region (2018)
  • Figure 02: Global Meningococcal Vaccine Market Value Share By Product Type (2019E)
  • Figure 03: Global Meningococcal Vaccine Market Value Share By Age Group (2019E)
  • Figure 04: Global Meningococcal Vaccine Market Value Share By Distribution Channel (2019E)
  • Figure 05: Global Meningococcal Vaccine Market Value Share By Region (2019E)
  • Figure 06: Predominant Serogroups Associated with Invasive Meningococcal Disease Worldwide
  • Figure 07: A Complex Journey of Vaccines
  • Figure 08: Distribution of Industry Sponsored Clinical Programs for Meningococcal Vaccines, by Phase
  • Figure 09: Distribution of Industry Sponsored Clinical Programs for Meningococcal Vaccines, by Age Group
  • Figure 10: Geographical Distribution of Clinical Trials for Meningococcal Vaccines (2017)
  • Figure 11: Global Meningococcal Vaccine Market Value Analysis (US$ Mn), 2014-2018
  • Figure 12: Global Meningococcal Vaccine Market Value Analysis (US$ Mn), 2019-2029
  • Figure 13: Global Meningococcal Vaccine Market Absolute $ Opportunity, 2014-2018
  • Figure 14: Global Meningococcal Vaccine Market Absolute $ Opportunity, 2019-2029
  • Figure 15: Tiered-price Policies Among Vaccine Manufacturers
  • Figure 16: Biotechnology Mergers and Acquisition Transactions and Number of deals (2013-2017)
  • Figure 17: Meningococcal Vaccine Immunization Coverage (Mn people) in Africa (2011-2017)
  • Figure 18: Weekly number of suspected meningitis cases - Nigeria, December 2016-June 2017
  • Figure 19: Gavi Transition Process
  • Figure 20: Gavi's Strategic Demand (2014-2016) and Forecast Meningococcal A Vaccine Requirements (2017-2030)
  • Figure 21: Global Coverage of Older Vaccines vs. Newer Vaccines (2016)
  • Figure 22: Opportunities in Emerging Markets
  • Figure 23: Global Vaccines Market Analysis (2018)
  • Figure 24: Global Meningococcal Vaccine Market Share Analysis (%) By Product Type, 2019 & 2029
  • Figure 25: Global Meningococcal Vaccine Market Y-o-Y Growth (%) By Product Type, 2019-2029
  • Figure 26: Global Meningococcal Vaccine Market Attractiveness Analysis, By Product Type
  • Figure 27: Global Meningococcal Vaccine Market Share Analysis (%) By Age Group , 2019 & 2029
  • Figure 28: Global Meningococcal Vaccine Market Y-o-Y Growth (%) By Age Group , 2019-2029
  • Figure 29: Global Meningococcal Vaccine Market Attractiveness Analysis, By Age Group
  • Figure 30: Global Meningococcal Vaccine Market Share Analysis (%) By Distribution Channel, 2019 & 2029
  • Figure 31: Global Meningococcal Vaccine Market Y-o-Y Growth (%) By Distribution Channel, 2019-2029
  • Figure 32: Global Meningococcal Vaccine Market Attractiveness Analysis, By Distribution Channel
  • Figure 33: Global Meningococcal Vaccine Market Share Analysis (%) By Region, 2019 & 2029
  • Figure 34: Global Meningococcal Vaccine Market Y-o-Y Growth (%) By Region, 2019-2029
  • Figure 35: Global Meningococcal Vaccine Market Attractiveness Analysis, By Region
  • Figure 36: North America Meningococcal Vaccine Market Size (US$ Mn), 2014-2018
  • Figure 37: North America Meningococcal Vaccine Market Size (US$) & Y-o-Y Growth (%), 2019-2029
  • Figure 38: North America Meningococcal Vaccine Market Analysis by Country - 2019 & 2029
  • Figure 39: North America Meningococcal Vaccine Market Y-o-Y Growth Projections by Country, 2019-2029
  • Figure 40: North America Meningococcal Vaccine Market Attractiveness Analysis by Country, 2019-2029
  • Figure 41: North America Meningococcal Vaccine Market Analysis by Product Type - 2019 & 2029
  • Figure 42: North America Meningococcal Vaccine Market Y-o-Y Growth Projections by Product Type, 2019-2029
  • Figure 43: North America Meningococcal Vaccine Market Attractiveness Analysis by Product Type, 2019-2029
  • Figure 44: North America Meningococcal Vaccine Market Analysis by Age Group -2019 & 2029
  • Figure 45: North America Meningococcal Vaccine Market Y-o-Y Growth Projections by Age Group , 2019-2029
  • Figure 46: North America Meningococcal Vaccine Market Attractiveness Analysis by Age Group , 2019-2029
  • Figure 47: North America Meningococcal Vaccine Market Analysis by Distribution Channel -2019 & 2029
  • Figure 48: North America Meningococcal Vaccine Market Y-o-Y Growth Projections by Distribution Channel, 2019-2029
  • Figure 49: North America Meningococcal Vaccine Market Attractiveness Analysis by Distribution Channel, 2019-2029
  • Figure 50: North America Meningococcal Vaccines Market Company Share Analysis (2018)
  • Figure 51: Latin America Meningococcal Vaccine Market Size (US$ Mn), 2014-2018
  • Figure 52: Latin America Meningococcal Vaccine Market Size (US$) & Y-o-Y Growth (%), 2019-2029
  • Figure 53: Latin America Meningococcal Vaccine Market Analysis by Country - 2019 & 2029
  • Figure 54: Latin America Meningococcal Vaccine Market Y-o-Y Growth Projections by Country, 2019-2029
  • Figure 55: Latin America Meningococcal Vaccine Market Attractiveness Analysis by Country, 2019-2029
  • Figure 56: Latin America Meningococcal Vaccine Market Analysis by Product Type - 2019 & 2029
  • Figure 57: Latin America Meningococcal Vaccine Market Y-o-Y Growth Projections by Product Type, 2019-2029
  • Figure 58: Latin America Meningococcal Vaccine Market Attractiveness Analysis by Product Type, 2019-2029
  • Figure 59: Latin America Meningococcal Vaccine Market Analysis by Age Group -2019 & 2029
  • Figure 60: Latin America Meningococcal Vaccine Market Y-o-Y Growth Projections by Age Group , 2019-2029
  • Figure 61: Latin America Meningococcal Vaccine Market Attractiveness Analysis by Age Group , 2019-2029
  • Figure 62: Latin America Meningococcal Vaccine Market Analysis by Distribution Channel -2019 & 2029
  • Figure 63: Latin America Meningococcal Vaccine Market Y-o-Y Growth Projections by Distribution Channel, 2019-2029
  • Figure 64: Latin America Meningococcal Vaccine Market Attractiveness Analysis by Distribution Channel, 2019-2029
  • Figure 65: Latin America Meningococcal Vaccines Market Company Share Analysis (2018)
  • Figure 66: Europe Meningococcal Vaccine Market Size (US$ Mn), 2014-2018
  • Figure 67: Europe Meningococcal Vaccine Market Size (US$) & Y-o-Y Growth (%), 2019-2029
  • Figure 68: Europe Meningococcal Vaccine Market Analysis by Country - 2019 & 2029
  • Figure 69: Europe Meningococcal Vaccine Market Y-o-Y Growth Projections by Country, 2019-2029
  • Figure 70: Europe Meningococcal Vaccine Market Attractiveness Analysis by Country, 2019-2029
  • Figure 71: Europe Meningococcal Vaccine Market Analysis by Product Type - 2019 & 2029
  • Figure 72: Europe Meningococcal Vaccine Market Y-o-Y Growth Projections by Product Type, 2019-2029
  • Figure 73: Europe Meningococcal Vaccine Market Attractiveness Analysis by Product Type, 2019-2029
  • Figure 74: Europe Meningococcal Vaccine Market Analysis by Age Group -2019 & 2029
  • Figure 75: Europe Meningococcal Vaccine Market Y-o-Y Growth Projections by Age Group , 2019-2029
  • Figure 76: Europe Meningococcal Vaccine Market Attractiveness Analysis by Age Group , 2019-2029
  • Figure 77: Europe Meningococcal Vaccine Market Analysis by Distribution Channel -2019 & 2029
  • Figure 78: Europe Meningococcal Vaccine Market Y-o-Y Growth Projections by Distribution Channel, 2019-2029
  • Figure 79: Europe Meningococcal Vaccine Market Attractiveness Analysis by Distribution Channel, 2019-2029
  • Figure 80: Europe Meningococcal Vaccines Market Company Share Analysis (2018)
  • Figure 81: East Asia Meningococcal Vaccine Market Size (US$ Mn), 2014-2018
  • Figure 82: East Asia Meningococcal Vaccine Market Size (US$) & Y-o-Y Growth (%), 2019-2029
  • Figure 83: East Asia Meningococcal Vaccine Market Analysis by Country - 2019 & 2029
  • Figure 84: East Asia Meningococcal Vaccine Market Y-o-Y Growth Projections by Country, 2019-2029
  • Figure 85: East Asia Meningococcal Vaccine Market Attractiveness Analysis by Country, 2019-2029
  • Figure 86: East Asia Meningococcal Vaccine Market Analysis by Product Type - 2019 & 2029
  • Figure 87: East Asia Meningococcal Vaccine Market Y-o-Y Growth Projections by Product Type, 2019-2029
  • Figure 88: East Asia Meningococcal Vaccine Market Attractiveness Analysis by Product Type, 2019-2029
  • Figure 89: East Asia Meningococcal Vaccine Market Analysis by Age Group -2019 & 2029
  • Figure 90: East Asia Meningococcal Vaccine Market Y-o-Y Growth Projections by Age Group , 2019-2029
  • Figure 91: East Asia Meningococcal Vaccine Market Attractiveness Analysis by Age Group , 2019-2029
  • Figure 92: East Asia Meningococcal Vaccine Market Analysis by Distribution Channel -2019 & 2029
  • Figure 93: East Asia Meningococcal Vaccine Market Y-o-Y Growth Projections by Distribution Channel, 2019-2029
  • Figure 94: East Asia Meningococcal Vaccine Market Attractiveness Analysis by Distribution Channel, 2019-2029
  • Figure 95: East Asia Meningococcal Vaccines Market Company Share Analysis (2018)
  • Figure 96: South Asia Meningococcal Vaccine Market Size (US$ Mn), 2014-2018
  • Figure 97: South Asia Meningococcal Vaccine Market Size (US$) & Y-o-Y Growth (%), 2019-2029
  • Figure 98: South Asia Meningococcal Vaccine Market Analysis by Country - 2019 & 2029
  • Figure 99: South Asia Meningococcal Vaccine Market Y-o-Y Growth Projections by Country, 2019-2029
  • Figure 100: South Asia Meningococcal Vaccine Market Attractiveness Analysis by Country, 2019-2029
  • Figure 101: South Asia Meningococcal Vaccine Market Analysis by Product Type - 2019 & 2029
  • Figure 102: South Asia Meningococcal Vaccine Market Y-o-Y Growth Projections by Product Type, 2019-2029
  • Figure 103: South Asia Meningococcal Vaccine Market Attractiveness Analysis by Product Type, 2019-2029
  • Figure 104: South Asia Meningococcal Vaccine Market Analysis by Age Group -2019 & 2029
  • Figure 105: South Asia Meningococcal Vaccine Market Y-o-Y Growth Projections by Age Group , 2019-2029
  • Figure 106: South Asia Meningococcal Vaccine Market Attractiveness Analysis by Age Group , 2019-2029
  • Figure 107: South Asia Meningococcal Vaccine Market Analysis by Distribution Channel -2019 & 2029
  • Figure 108: South Asia Meningococcal Vaccine Market Y-o-Y Growth Projections by Distribution Channel, 2019-2029
  • Figure 109: South Asia Meningococcal Vaccine Market Attractiveness Analysis by Distribution Channel, 2019-2029
  • Figure 110: South Asia Meningococcal Vaccines Market Company Share Analysis (2018)
  • Figure 111: Oceania Meningococcal Vaccine Market Size (US$ Mn), 2014-2018
  • Figure 112: Oceania Meningococcal Vaccine Market Size (US$) & Y-o-Y Growth (%), 2019-2029
  • Figure 113: Oceania Meningococcal Vaccine Market Analysis by Country - 2019 & 2029
  • Figure 114: Oceania Meningococcal Vaccine Market Y-o-Y Growth Projections by Country, 2019-2029
  • Figure 115: Oceania Meningococcal Vaccine Market Attractiveness Analysis by Country, 2019-2029
  • Figure 116: Oceania Meningococcal Vaccine Market Analysis by Product Type - 2019 & 2029
  • Figure 117: Oceania Meningococcal Vaccine Market Y-o-Y Growth Projections by Product Type, 2019-2029
  • Figure 118: Oceania Meningococcal Vaccine Market Attractiveness Analysis by Product Type, 2019-2029
  • Figure 119: Oceania Meningococcal Vaccine Market Analysis by Age Group -2019 & 2029
  • Figure 120: Oceania Meningococcal Vaccine Market Y-o-Y Growth Projections by Age Group , 2019-2029
  • Figure 121: Oceania Meningococcal Vaccine Market Attractiveness Analysis by Age Group , 2019-2029
  • Figure 122: Oceania Meningococcal Vaccine Market Analysis by Distribution Channel -2019 & 2029
  • Figure 123: Oceania Meningococcal Vaccine Market Y-o-Y Growth Projections by Distribution Channel, 2019-2029
  • Figure 124: Oceania Meningococcal Vaccine Market Attractiveness Analysis by Distribution Channel, 2019-2029
  • Figure 125: Oceania Meningococcal Vaccines Market Company Share Analysis (2018)
  • Figure 126: MEA Meningococcal Vaccine Market Size (US$ Mn), 2014-2018
  • Figure 127: MEA Meningococcal Vaccine Market Size (US$) & Y-o-Y Growth (%), 2019-2029
  • Figure 128: MEA Meningococcal Vaccine Market Analysis by Country - 2019 & 2029
  • Figure 129: MEA Meningococcal Vaccine Market Y-o-Y Growth Projections by Country, 2019-2029
  • Figure 130: MEA Meningococcal Vaccine Market Attractiveness Analysis by Country, 2019-2029
  • Figure 131: MEA Meningococcal Vaccine Market Analysis by Product Type - 2019 & 2029
  • Figure 132: MEA Meningococcal Vaccine Market Y-o-Y Growth Projections by Product Type, 2019-2029
  • Figure 133: MEA Meningococcal Vaccine Market Attractiveness Analysis by Product Type, 2019-2029
  • Figure 134: MEA Meningococcal Vaccine Market Analysis by Age Group -2019 & 2029
  • Figure 135: MEA Meningococcal Vaccine Market Y-o-Y Growth Projections by Age Group , 2019-2029
  • Figure 136: MEA Meningococcal Vaccine Market Attractiveness Analysis by Age Group , 2019-2029
  • Figure 137: MEA Meningococcal Vaccine Market Analysis by Distribution Channel -2019 & 2029
  • Figure 138: MEA Meningococcal Vaccine Market Y-o-Y Growth Projections by Distribution Channel, 2019-2029
  • Figure 139: MEA Meningococcal Vaccine Market Attractiveness Analysis by Distribution Channel, 2019-2029
  • Figure 140: MEA Meningococcal Vaccines Market Company Share Analysis (2018)
  • Figure 141: China Meningococcal Vaccine Market Size (US$ Mn), 2014-2018
  • Figure 142: China Meningococcal Vaccine Market Size (US$) & Y-o-Y Growth (%), 2019-2029
  • Figure 143: China Meningococcal Vaccine Market Analysis by Product Type - 2019 & 2029
  • Figure 144: China Meningococcal Vaccine Market Y-o-Y Growth Projections by Product Type, 2019-2029
  • Figure 145: China Meningococcal Vaccine Market Attractiveness Analysis by Product Type, 2019-2029
  • Figure 146: China Meningococcal Vaccine Market Analysis by Age Group -2019 & 2029
  • Figure 147: China Meningococcal Vaccine Market Y-o-Y Growth Projections by Age Group , 2019-2029
  • Figure 148: China Meningococcal Vaccine Market Attractiveness Analysis by Age Group , 2019-2029
  • Figure 149: China Meningococcal Vaccine Market Analysis by Distribution Channel -2019 & 2029
  • Figure 150: China Meningococcal Vaccine Market Y-o-Y Growth Projections by Distribution Channel, 2019-2029
  • Figure 151: China Meningococcal Vaccine Market Attractiveness Analysis by Distribution Channel, 2019-2029
  • Figure 152: India Meningococcal Vaccine Market Size (US$ Mn), 2014-2018
  • Figure 153: India Meningococcal Vaccine Market Size (US$) & Y-o-Y Growth (%), 2019-2029
  • Figure 154: India Meningococcal Vaccine Market Analysis by Product Type - 2019 & 2029
  • Figure 155: India Meningococcal Vaccine Market Y-o-Y Growth Projections by Product Type, 2019-2029
  • Figure 156: India Meningococcal Vaccine Market Attractiveness Analysis by Product Type, 2019-2029
  • Figure 157: India Meningococcal Vaccine Market Analysis by Age Group -2019 & 2029
  • Figure 158: India Meningococcal Vaccine Market Y-o-Y Growth Projections by Age Group , 2019-2029
  • Figure 159: India Meningococcal Vaccine Market Attractiveness Analysis by Age Group , 2019-2029
  • Figure 160: India Meningococcal Vaccine Market Analysis by Distribution Channel -2019 & 2029
  • Figure 161: India Meningococcal Vaccine Market Y-o-Y Growth Projections by Distribution Channel, 2019-2029
  • Figure 162: India Meningococcal Vaccine Market Attractiveness Analysis by Distribution Channel, 2019-2029
  • Figure 163: Brazil Meningococcal Vaccine Market Size (US$ Mn), 2014-2018
  • Figure 164: Brazil Meningococcal Vaccine Market Size (US$) & Y-o-Y Growth (%), 2019-2029
  • Figure 165: Brazil Meningococcal Vaccine Market Analysis by Product Type - 2019 & 2029
  • Figure 166: Brazil Meningococcal Vaccine Market Y-o-Y Growth Projections by Product Type, 2019-2029
  • Figure 167: Brazil Meningococcal Vaccine Market Attractiveness Analysis by Product Type, 2019-2029
  • Figure 168: Brazil Meningococcal Vaccine Market Analysis by Age Group -2019 & 2029
  • Figure 169: Brazil Meningococcal Vaccine Market Y-o-Y Growth Projections by Age Group , 2019-2029
  • Figure 170: Brazil Meningococcal Vaccine Market Attractiveness Analysis by Age Group , 2019-2029
  • Figure 171: Brazil Meningococcal Vaccine Market Analysis by Distribution Channel -2019 & 2029
  • Figure 172: Brazil Meningococcal Vaccine Market Y-o-Y Growth Projections by Distribution Channel, 2019-2029
  • Figure 173: Brazil Meningococcal Vaccine Market Attractiveness Analysis by Distribution Channel, 2019-2029
  • Figure 174: Global Meningococcal Vaccines Market Company Share Analysis (2018)
Back to Top